User profiles for Paraskevi Giannakakou

Paraskevi Giannakakou

Professor of pharmacology in Medicine, Weill Cornell
Verified email at med.cornell.edu
Cited by 17795

Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation

…, JR Cubillos-Ruiz, G Galletti, P Giannakakou… - Nature cell …, 2018 - nature.com
The heterogeneity of exosomal populations has hindered our understanding of their biogenesis,
molecular composition, biodistribution and functions. By employing asymmetric flow field…

[PDF][PDF] 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF

…, MT Willard, H Zhong, JW Simons, P Giannakakou - Cancer cell, 2003 - cell.com
Inhibition of angiogenesis is an important new modality for cancer treatment. 2-methoxyestradiol
(2ME2) is a novel antitumor and antiangiogenic agent, currently in clinical trials, whose …

[HTML][HTML] Paclitaxel-resistant human ovarian cancer cells have mutant β-tubulins that exhibit impaired paclitaxel-driven polymerization

P Giannakakou, DL Sackett, YK Kang, Z Zhan… - Journal of Biological …, 1997 - ASBMB
Acquired resistance to paclitaxel can be mediated by P-glycoprotein or by alterations
involving tubulin. We report two paclitaxel-resistant sublines derived from 1A9 human ovarian …

[HTML][HTML] Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol®)

RJ Kowalski, P Giannakakou, E Hamel - Journal of Biological Chemistry, 1997 - ASBMB
Epothilones A and B, natural products with minimal structural analogy to taxoids, have effects
similar to those of paclitaxel (Taxol®) in cultured cells and on microtubule protein, but differ …

Targeting microtubules for cancer chemotherapy

J Zhou, P Giannakakou - Current Medicinal Chemistry-Anti …, 2005 - ingentaconnect.com
Chemical compounds that interfere with microtubules such as the vinca alkaloids and taxanes
are important chemotherapeutic agents for the treatment of cancer. As our knowledge of …

A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells

P Giannakakou, R Gussio, E Nogales… - Proceedings of the …, 2000 - National Acad Sciences
The epothilones are naturally occurring antimitotic drugs that share with the taxanes a similar
mechanism of action without apparent structural similarity. Although photoaffinity labeling …

Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer

…, ST Tagawa, NH Bander, DM Nanus, P Giannakakou - Cancer research, 2011 - AACR
Prostate cancer progression requires active androgen receptor (AR) signaling which occurs
following translocation of AR from the cytoplasm to the nucleus. Chemotherapy with taxanes …

[HTML][HTML] Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase …

TH Wang, HS Wang, H Ichijo, P Giannakakou… - Journal of Biological …, 1998 - ASBMB
The essential cellular functions associated with microtubules have led to a wide use of
microtubule-interfering agents in cancer chemotherapy with promising results. Although the most …

p53 is associated with cellular microtubules and is transported to the nucleus by dynein

P Giannakakou, DL Sackett, Y Ward, KR Webster… - Nature cell …, 2000 - nature.com
Here we show that p53 protein is physically associated with tubulin in vivo and in vitro, and
that it localizes to cellular microtubules. Treatment with vincristine or paclitaxel before DNA-…

Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate …

…, ST Tagawa, DM Nanus, PA Giannakakou… - Lab on a Chip, 2010 - pubs.rsc.org
Geometrically enhanced differential immunocapture (GEDI) and an antibody for prostate-specific
membrane antigen (PSMA) are used for high-efficiency and high-purity capture of …